Resilient & Accelerated Scale-up of DMPA-SC/Self-injection in Nigeria (RASuDiN) Second Year Milestones with COVID-19 Adaptations

Click image to view more details

Despite the COVID-19 pandemic in Nigeria, the Resilient & Accelerated Scale-up of DMPA-SC/Self-injection in Nigeria (RASuDiN) Project continues to demonstrate the feasibility of expanding access to Family Planning (FP) method uptake, increase self-care among women of reproductive age (WRA) and improving continuation rate of Depot Medroxy Progesterone Acetate Subcutaneous/Self Injection (DMPA SC/SI).

Read and share.

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on whatsapp
WhatsApp
Share on telegram
Telegram
Share on email
Email

Let's engage.

Stay updated

Get notified with updates from ARFH as it happens. Please subscribe now.